Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Published: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Cardiovascular Disorders
Published in:

Open Access 01-12-2024 | Research

Association between homocysteine levels and mortality in CVD: a cohort study based on NHANES database

Authors: Donghao Liu, Chuangsen Fang, Jia Wang, Yuqing Tian, Tong Zou

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

Cardiovascular disease (CVD) is a major global health concern with increasing incident cases and deaths. Homocysteine (Hcy) has been investigated for its potential association with CVD, researchers have debated the extent to which Hcy should be considered a risk factor for cardiovascular diseases, as only 50% of CVD can be explained by classical risk factors.

Methods

We conducted a prospective cohort study using NHANES 1999–2006 data, analyzing 1,739 US patients aged at least 30 with CVD. Cox proportional hazards regression and restricted cubic splines were used to examine the relationship between Hcy levels and mortality, adjusting for covariates.

Result

A total of 1,739 participants with cardiovascular disease (CVD) were enrolled, with a median follow-up period of 126 months. Among them, 1,194 participants died, including 501 deaths due to cardiovascular causes. After adjusting for covariates, the hazard ratios (HR) and 95% confidence intervals (CI) for CVD mortality at different levels of homocysteine (Hcy) (T1 (< 9.3), T2 (9.3–12.5), T3 (> 12.5)) were 1.26 (0.92, 1.73) (T2), and 1.69 (1.14, 2.51) (T3) (P for trend = 0.0086). The HR and 95% CI for all-cause mortality at different levels of Hcy were 1.22 (1.05, 1.42) (T2) and 1.64 (1.29, 2.09) (T3) (P for trend < 0.0001). Elevated Hcy levels were associated with increased risks of all-cause mortality and CVD deaths, even at levels below the conventional threshold. The nonlinear relationship was observed, with inflection points at 14.5 µmol/L for all-cause mortality and 14.6 µmol/L for CVD mortality. Subgroup analyses revealed interactions with age, serum vitamin B12, and smoking.

Conclusion

Our study supports the notion that elevated Hcy levels are associated with higher all-cause and CVD mortality risks in CVD participants. The impact of Hcy on health outcomes can be observed at lower concentrations than previously thought.
Appendix
Available only for authorised users
Literature
1.
2.
Li Y, Cao GY, Jing WZ, Liu J, Liu M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990–2019: findings from 2019 global burden of disease study. Eur J Prev Cardiol. 2023;30(3):276–86.CrossRefPubMed
3.
Baszczuk A, Kopczyński Z. [Hyperhomocysteinemia in patients with cardiovascular disease]. Postepy Hig Med Dosw (Online). 2014;68:579–89.CrossRefPubMed
4.
5.
6.
Peng HY, Man CF, Xu J, Fan Y. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies. J Zhejiang Univ Sci B. 2015;16(1):78–86.CrossRefPubMedPubMedCentral
7.
Zhang Z, Gu X, Fang X, Tang Z, Guan S, Liu H, Wu X, Wang C, Zhao Y. Homocysteine and the risk of Cardiovascular events and all-cause death in Elderly Population: A Community-based prospective cohort study. Ther Clin Risk Manag. 2020;16:471–81.CrossRefPubMedPubMedCentral
8.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.CrossRefPubMedPubMedCentral
9.
Kursa MB, Rudnicki WR. Feature selection with the Boruta Package. J Stat Softw. 2010;36(11):1–13.CrossRef
10.
11.
12.
Fadeyev K, Nagao-Sato S, Reicks M. Nutrient and Food Group Intakes among U.S. Children (2–5 Years) Differ by Family Income to Poverty Ratio, NHANES 2011–2018. Int J Environ Res Public Health. 2021;18(22).
13.
14.
Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and cystatin C-Based equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–49.CrossRefPubMedPubMedCentral
15.
Kutner MH, Nachtsheim CJ, Neter J, Wasserman W. Applied linear regression models. Volume 4. McGraw-Hill/Irwin New York; 2004.
16.
Harrell FE. General Aspects of Fitting Regression Models. In: Regression Model­ing Strategies: With Applications to Linear Models, Logistic and Ordinal Regres­sion, and Survival Analysis. Edited by Harrell JFE. Cham: Springer International Publishing; 2015 13–44.
17.
Fan R, Zhang A, Zhong F. Association between homocysteine levels and all-cause mortality: a dose-response Meta-analysis of prospective studies. Sci Rep. 2017;7(1):4769.CrossRefPubMedPubMedCentral
18.
Peng H-y, Man C-f, Xu J, Fan Y. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies. J Zhejiang Univ Sci B. 2015;16(1):78–86.
19.
Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337(4):230–6.CrossRefPubMed
20.
Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang C-H, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and DeathThe Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA. 2004;291(5):565–75.CrossRefPubMed
21.
Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr. 2000;130(2S Suppl):s365–8.CrossRef
22.
Perna AF, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, De Santo NG. Possible mechanisms of homocysteine toxicity. Kidney Int Suppl 2003(84):S137–140.
23.
24.
Huang T, Yuan G, Zhang Z, Zou Z, Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr. 2008;17(1):8–16.PubMed
25.
Yang Q, He GW. Imbalance of Homocysteine and H(2)S: Significance, Mechanisms, and Therapeutic Promise in Vascular Injury. Oxid Med Cell Longev. 2019:7629673.
26.
Paganelli F, Mottola G, Fromonot J, Marlinge M, Deharo P, Guieu R, Ruf J. Hyperhomocysteinemia and Cardiovascular Disease: is the Adenosinergic System the Missing Link? Int J Mol Sci. 2021; 22(4).
27.
Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr. 2019;6:49.CrossRefPubMedPubMedCentral
28.
Liu Y, Geng T, Wan Z, Lu Q, Zhang X, Qiu Z, Li L, Zhu K, Liu L, Pan A, et al. Associations of serum folate and vitamin B12 levels with Cardiovascular Disease Mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5(1):e2146124.CrossRefPubMedPubMedCentral
29.
Verhaar MC, Stroes E, Rabelink TJ. Folates and Cardiovascular Disease. ATVB. 2022;22(1):6–13.
30.
Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost. 2005;94(5):907–15.PubMed
31.
Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007;131(6):872–84.
32.
Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q. Gender- and age-related differences in homocysteine concentration: a c ross-sectional study of the general population of China. Sci Rep. 2020;10(1):17401.
33.
Zhao J, Li Z, Hou C, Sun F, Dong J, Chu X, Guo Y. Gender differences in risk factors for high plasma homocysteine levels based on a retrospective checkup cohort using a generalized estimating equation analysis. Lipids Health Dis. 2021;20(1):31.CrossRefPubMedPubMedCentral
34.
Sun J, Han W, Wu S, Jia S, Yan Z, Guo Y, Zhao Y, Zhou Y, Liu X. Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study. BMC Cardiovasc Disord. 2021;21(1):484.CrossRefPubMedPubMedCentral
35.
Yuan D, Chu J, Lin H, Zhu G, Qian J, Yu Y, Yao T, Ping F, Chen F, Liu X. Mechanism of homocysteine-mediated endothelial injury and its conseque nces for atherosclerosis. Front Cardiovasc Med. 2023;9.
36.
O’Callaghan P, Meleady R, Fitzgerald T, Graham I. Smoking and plasma homocysteine. Eur Heart J. 2002;23(20):1580–6.CrossRefPubMed
37.
Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q. Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep. 2020;10(1):17401.CrossRefPubMedPubMedCentral
38.
Ostrakhovitch EA, Tabibzadeh S. Homocysteine and age-associated disorders. Ageing Res Rev. 2019;49:144–64.CrossRefPubMed
39.
Kuo H-K, Sorond FA, Chen J-H, Hashmi A, Milberg WP, Lipsitz LA. The role of homocysteine in multisystem age-related problems: a system atic review. J Gerontol Biol Sci Med Sci. 2005;60(9):1190–201.
40.
O’Callaghan P. Smoking and plasma homocysteine. Eur Heart J. 2022;23(20):1580–6.
41.
Stehouwer CD, van Guldener C. Does homocysteine cause hypertension? Clin Chem Lab Med. 2003;41(11):1408–11.CrossRefPubMed
42.
Elias MF, Brown CJ. New evidence for Homocysteine lowering for management of treatment-res istant hypertension. Am J Hypertens. 2022;35(4):303–5.
43.
Platt DE, Hariri E, Salameh P, Merhi M, Sabbah N, Helou M, Mouzaya F, Nemer R, Al-Sarraj Y, El-Shanti H et al. Type II diabetes mellitus and hyperhomocysteinemia: a complex interact ion. Diabetol Metab Syndr. 2017;9:19.
44.
Huang T, Ren J, Huang J, Li D. Association of homocysteine with type 2 diabetes: a meta-analysis implementing mendelian randomization approach. BMC Genomics. 2013;14:867.CrossRefPubMedPubMedCentral
45.
Lei X, Zeng G, Zhang Y, Li Q, Zhang J, Bai Z, Yang K. Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2018;10:61.CrossRefPubMedPubMedCentral
46.
Fratoni V, Brandi ML. B vitamins, homocysteine and bone health. Nutrients. 2015;7(4):2176–92.
47.
Metadata
Title
Association between homocysteine levels and mortality in CVD: a cohort study based on NHANES database
Authors
Donghao Liu
Chuangsen Fang
Jia Wang
Yuqing Tian
Tong Zou
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-04317-9

Other articles of this Issue 1/2024

Two surgical strategies (early carotid reperfusion vs. Central aortic repair-first) of acute type a aortic dissection complicated with cerebral malperfusion syndrome: a meta-analysis and systematic review

The role of COX2 deficiency attenuates cardiac damage in acute myocardial infarction

Development and validation of a novel combinatorial nomogram model to predict in-hospital deaths in heart failure patients

Genetically predicted hypothyroidism, thyroid hormone treatment, and the risk of cardiovascular diseases: a mendelian randomization study

Apolipoprotein E E3/E4 genotype is associated with an increased risk of premature coronary artery disease

Waist-to-hip ratio as a contributor associated with higher atherosclerotic cardiovascular disease risk assessment in patients with diabetes: a cross-sectional study

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now
Image Credits